ID: MRFR/LS/4835-CR | January 2020 | Region: Global | 78 pages
The primary human cells of the body are placed into isolation from the normal human body tissue or the blood cells with the help of either the enzymatic method or the mechanical one. The primary cells are successful in retaining their fundamental cellular functions. This is one of the main reasons that is having an impact on their demand. These cells are significantly used in the cell-based conducted research programs. The primary cell culture is beneficial for these research programs and hence, there is a rapid growth expected. The biotechnology and biopharmaceutical producers and manufacturers are demanding these in a high ratio because of the growing development towards cancer research. Also, there is an increase in the adoption of primary cells in the cell lines along with an increase in the demand for the availability of monoclonal antibodies.
The need of the hour is to increase the expenditure dedicated for the development of healthcare infrastructure and facilities that also require a wide demand for the advanced primary cells. This is expecting the primary cells market to register a growth of 8.13% CAGR by the end of the forecast period ending in 2025 reaching a market valuation that sums up to USD 1,233.67 million.
COVID 19 Analysis
The coronavirus was declared as a pandemic in WHO. Since then, the world economies are coming up with various steps that will help in curbing the spread of the virus. From developing the healthcare infrastructure to mass production of vaccinations for the world to fight the pandemic, many efforts are on the way. The virus is becoming deadlier with each wave and to stop the spread, the only option is to impose permanent and permanent lockdown restrictions. The production units are suffering because of this and are unable to meet the demand. There are steady steps on the way to cover the losses and hence, make the availability of these primary human cells to care for the need of patients suffering from cancer.
The government is focusing on the development of sturdy and robust healthcare infrastructure along with supporting the primary cells market players in their research and development initiatives. Also, they are analyzing their key market strategies to help the market reach the predicted valuation by the end of the global forecast period in 2025.
Global Primary Cells Market, by Source, 2018 & 2025 (USD Million)
Source: MRFR Analysis
The human primary cells market is witnessing a major boost due to an increase in the ongoing research for cancer and the development of its treatment. Also, the research departments are increasing their preference for the primary cells of the immune system to research along with the development and implementation of new drug acts. These are likely to bring along major growth opportunities for the primary cells market period ending in 2025.
Certain challenges need to be dissolved by the market to grow as per the estimated CAGR percentage. The cost associated with acquiring these primary cells for the research purpose is quite high and there is a major risk of contamination. These risks are questionable and need to be dissolved for promising growth for the primary cells market.
Cancer research is growing at a staggering rate all over the world. Cancer is known to be one of the major death causes in the world and also is becoming a very common disease. A lot of research institutions along with pharmaceutical and medical companies are on the way to developing drugs that help in the development of treatment to cure cancer. The development is one the way by making use of the cell structure. The demand for such research initiatives is high with a motive to develop new drugs. The rising cancer cases are alarming and hence, medical aid needs urgent development for the same.
Global Primary Cells Market Share, by Region, 2018 & 2025 (USD Million)
Source: MRFR Analysis
The primary cells market share is depending on the functioning of the market segments in various regions of the world. The primary cells market includes various segments to target the products, applications, market end-users, and regions. The primary structures in the animal cells market have been segmented based on the following:
Based on the source
The sources include skin and gastrointestinal cells, liver, and lung cells, hematopoietic, muscle, and skeletal cells.
Based on the type
These cells have been divided into the human primary cells along with the animal primary cells. The primary cells market by type has these divisions to conduct cancer-related research.
Based on the market end-users
The research institutions, biotechnology along pharmaceutical companies are the major end-users of these primary cells.
The primary cells market is divided into regions like America, the Middle East, and Africa, along with the APAC region. The largest primary cells market share is expected to be held by the American region. The reason behind this level of growth for the primary cells market is attributed to the presence of an extremely well system of the healthcare system for treating patients diagnosed with cancer and developing advancements needed for the same.
The second-largest market share is likely to be enjoyed by the European nations including Germany, Italy, Spain, France, UK, along with other countries in the region. There is an evolving presence of government laws and initiatives that are pushing the researches for the rising prevalence of cancer and other conditions that are lifestyle-oriented. The fastest-growing region in the forecast period of 2019-2025 is the APAC region. There is an increase in the geriatric population along with the development of the healthcare sector functioning in countries like China and Australia, India, and Japan. However, a lot of scope in the name of treatment facilities are available for the Middle East and African market to grow upon. The need is to work on the development of new initiatives and products for countries like Saudi Arabia.
The primary cell culture market is dependent on the strategies and growth goals taken up by the prominent market leaders on a global scale. These strategies are also prevalent to analyze the revenue models and draw a competitive landscape for the market while predicting the growth for the global period of 2019-2025. The key market players are as follows:
The primary cells market research report discusses the market overview and functioning that was disrupted because of the emergence of the coronavirus pandemic in 2020. The primary cells market report considers the opinions put forward by the market experts and industry leaders and then draws the market dynamics in the form of opportunities for growth and challenges available for the primary cells market. The primary cells market further discusses the segments in which the market has been divided into along with the potential in them to grow in the region of their functionality. Also, the report mentions the efforts of the prominent players in the market to draw a competitive graph. These will also help in predicting the growth rate for the primary cells market along with the market valuation that is expected to reach by the end of the forecast period in 2025 by the market.
|Market Size||2025: USD 1,233.67 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Source, Type and By End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||AllCells (US), American Type Culture Collection (ATCC) ( Virginia), Axol Bioscience Ltd (UK), Cell Biologics, Inc. (Chicago), Lonza Group, AG (Switzerland), Merck KGaA (Germany), PromoCell (UK), STEMCELL Technologies Inc. (Canada), ZenBio, Inc. (Research Triangle Park, NC), Thermo Fisher Scientific Inc. (US)|
|Key Market Opportunities||Increasing preference of primary cells in research and development to develop new drug acts|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The valuation of primary cells market would be USD 1,233.67 Million till 2025
The CAGR would be 8.13% during the forecast period for the primary cells market.
Primary cells market would be driven by growing cancer research, biotechnology and biopharmaceutical industries, the surge in demand for monoclonal antibodies, better adoption rate of primary cells over cell lines, and increasing healthcare expenditure.
High cost and contamination risk would prevent primary cells market from easy growth.
The Americas would be in charge of primary cells market.